Frontlight ResearchEarly access
Kidney cancer trials in Israel
1 of 8 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleAssociation Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
- Where
- Tel Aviv
- Age
- 18 years and over
- People
- 300
- Run by
- Daniel Keizman
See details and how to joinNCT07485114